Dr. Keating has over 20 years experience in infectious disease, immunopathology, and translational immunology. She leads clinical development of GigaGen’s recombinant hyperimmune gammaglobulin product in collaboration with pharmaceutical partner Grifols.
Dr. Keating has spent her career advancing the diagnosis and treatment of infectious and chronic disease through the study of immune biomarkers and immunopathology. She has been the recipient of multiple research grants and has led both pre-clinical and clinical projects in translational immunology research.